Abstract
Background. During the recent smallpox vaccination campaigns, ischemic cardiac complications were observed after vaccination. To examine a possible association between the smallpox vaccine and postvaccination ischemic events, we investigated alterations in levels of prothrombotic proteins (plasminogen activator inhibitor type 1 [PAI-1] and soluble CD40 ligand [sCD40L]) in recently vaccinated individuals. Methods. Vaccinia-naive (cohort N; aged 18-32 years) and vaccinia-experienced (cohort E; aged 33-49 years) healthy adults were vaccinated with a 1:5 dilution of the Aventis Pasteur smallpox vaccine. Plasma levels of PAI-1 and sCD40L were measured in 30 subjects (cohort N, n = 15; cohort E, n = 15) at baseline and twice after vaccination (between days 7 and 9 and between days 26 and 30). Results. Baseline mean PAI-1 levels significantly differed between cohorts N and E (P = .04). Within each exposure cohort, mean PAI-1 levels did not significantly change after vaccination. Baseline sCD40L levels did not differ between cohorts N and E. In cohort N, sCD40L levels significantly decreased after vaccination but returned to baseline levels within 1 month. Vaccination did not significantly alter levels of sCD40L in cohort E. Conclusions. Levels of PAI-1 and sCD40L did not significantly increase after smallpox vaccination. Vaccine-induced alterations in levels of these prothrombotic proteins do not appear to play a role in ischemic events observed after smallpox vaccination.
Original language | English (US) |
---|---|
Pages (from-to) | 724-730 |
Number of pages | 7 |
Journal | Journal of Infectious Diseases |
Volume | 191 |
Issue number | 5 |
DOIs | |
State | Published - Mar 1 2005 |
Funding
Financial support: Division of Microbiology and Infectious Diseases, National Institute of Allergy and Infectious Diseases (NIAID) (contract N01-AI-25462); General Clinical Research Center (grant M01-RR-00095); National Institutes of Health/ NIAID (grant RO1-AI-57661 to J.E.C.); Stanley J. Sarnoff Endowment for Cardiovascular Science (support to J.A.S.M.).
ASJC Scopus subject areas
- Immunology and Allergy
- Infectious Diseases